Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Cervical Cancer

  Free Subscription


02.02.2026

1 3 Biotech
1 Acta Obstet Gynecol Scand
1 AJOG Glob Rep
1 Am J Clin Pathol
1 Am J Emerg Med
1 Anal Methods
2 Arch Gynecol Obstet
1 Biology (Basel)
1 Biosensors (Basel)
2 BMC Cancer
1 BMC Health Serv Res
2 BMC Public Health
1 BMJ Oncol
1 CA Cancer J Clin
1 Cancer Control
1 Cancer Gene Ther
1 Cancer Genet
1 Cancer Lett
2 Cancer Med
3 Cancers (Basel)
1 Cells
1 Curr Med Chem
3 Curr Oncol
1 Curr Pharm Biotechnol
2 Digit Health
1 Ecancermedicalscience
1 Front Biosci (Landmark Ed)
3 Front Immunol
1 Front Oncol
1 Hum Mutat
1 In Silico Pharmacol
1 Infect Agent Cancer
1 Int Cancer Conf J
4 Int J Cancer
1 Int J Clin Oncol
1 Int J Gynaecol Obstet
1 Int J Gynecol Cancer
1 Int J Med Sci
3 Int J Mol Sci
1 Ir Med J
1 J Cell Mol Med
1 J Gynecol Oncol
1 J Health Popul Nutr
1 J Low Genit Tract Dis
1 J Surg Oncol
1 JNCI Cancer Spectr
2 Lancet Public Health
1 Life (Basel)
3 Medicina (Kaunas)
1 Medicine (Baltimore)
1 Mol Oncol
1 Molecules
1 Nat Commun
1 Nutrients
1 Oncol Lett
1 Oncol Res
1 Pharmaceuticals (Basel)
1 Public Health Res Pract
1 Reprod Health
2 Sci Rep
1 Virol J
1 Viruses
1 Zhonghua Fu Chan Ke Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    3 Biotech

  1. ANUPAMA CV, Devarapalli D, Ahammad SH, Eid MMA, et al
    Cervical cancer cell prediction and detection with high test accuracy based on a reliable automated system.
    3 Biotech. 2026;16:83.
    PubMed         Abstract available


    Acta Obstet Gynecol Scand

  2. ERIKSEN DO, Krog L, Ostenfeld EB, Jensen PT, et al
    HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression.
    Acta Obstet Gynecol Scand. 2026;105:377-385.
    PubMed         Abstract available


    AJOG Glob Rep

  3. NARTEY Y, Osae-Larbi J, Daniels J
    Cervical cancer screening in women with disabilities in Ghana: bridging the gap in access and equity.
    AJOG Glob Rep. 2025;6:100597.
    PubMed         Abstract available


    Am J Clin Pathol

  4. TONG Y, Xu L, Sun Y, Lan Y, et al
    Construction of a nomogram model for predicting residual or recurrent cervical intraepithelial neoplasia after the loop electrosurgical excision procedure.
    Am J Clin Pathol. 2026;165:aqaf125.
    PubMed         Abstract available


    Am J Emerg Med

  5. ABAR B, Wood N, Merriman J, Adler D, et al
    Test results and follow-up care stemming from an ED-based cervical cancer intervention.
    Am J Emerg Med. 2026;102:78-80.
    PubMed         Abstract available


    Anal Methods

  6. BRENNAN LP, Hamacher F, Claure LA, Claure Dips AL, et al
    Development of an HPV 16 rapid test founded in user-centered design with primary care clinicians.
    Anal Methods. 2026;18:786-799.
    PubMed         Abstract available


    Arch Gynecol Obstet

  7. GENNARI P, Luft D, Meszaros J, Ignatov A, et al
    Incidence, risk factors, and outcomes of ovarian metastasis in early-stage cervical cancer: a population-based analysis of 983 patients.
    Arch Gynecol Obstet. 2026;313:65.
    PubMed         Abstract available

  8. BALE CA, Pearce JV, Deng X, Bandyopadhyay D, et al
    Prognostic value of FDG-PET SUV changes in cervical cancer following radiation therapy: a retrospective cohort study.
    Arch Gynecol Obstet. 2026;313:66.
    PubMed         Abstract available


    Biology (Basel)

  9. MAREMA TP, Laka K, Mbita Z
    Medicinal Plants for Overcoming Drug Resistance in Cervical Cancer.
    Biology (Basel). 2026;15:191.
    PubMed         Abstract available


    Biosensors (Basel)

  10. ZAMUDIO CANAS R, Vallejo Ruiz V, Jaramillo Flores ME, Delgado Macuil RJ, et al
    Detection of Premalignant Cervical Lesions via Maackia amurensis Lectin-Based Biosensors.
    Biosensors (Basel). 2025;16:24.
    PubMed         Abstract available


    BMC Cancer

  11. YANG XL, He JL, Wang TJ, Ran L, et al
    Reappraisal of the prognostic significance of vaginal invasion, parametrial invasion and lymph node metastasis in locally advanced cervical cancer patients receiving concurrent chemoradiotherapy: a multi-center large cohort study.
    BMC Cancer. 2026 Jan 29. doi: 10.1186/s12885-026-15661.
    PubMed         Abstract available

  12. LIN S, Zhong J, Yuan S, Su M, et al
    Integrated single-cell and bulk RNA sequencing unravels neutrophil heterogeneity and validates SPP1 as a prognostic biomarker in cervical cancer.
    BMC Cancer. 2026 Jan 30. doi: 10.1186/s12885-026-15636.
    PubMed         Abstract available


    BMC Health Serv Res

  13. DANIELS-DONKOR SS, Marryat L
    Health system barriers and facilitators influencing the uptake of cervical cancer screening among women in sub-Saharan Africa: systematic review and meta-synthesis.
    BMC Health Serv Res. 2026 Jan 24. doi: 10.1186/s12913-026-14003.
    PubMed        


    BMC Public Health

  14. SIFERIH M, Gedif G, Lamesgen A, Alamneh AA, et al
    Point-of-care HPV testing for cervical cancer screening in Sub-Saharan Africa: platform diversity, diagnostic performance, implementation feasibility, and determinants-a scoping review with contextual considerations for Ethiopia.
    BMC Public Health. 2026 Jan 26. doi: 10.1186/s12889-026-26382.
    PubMed        

  15. LI W, Yan Q, Zhou D, Yin X, et al
    Disparities in early-stage cervical cancer detection: the critical role of educational attainment in 75,268 women in Hubei Province.
    BMC Public Health. 2026 Jan 26. doi: 10.1186/s12889-025-26056.
    PubMed        


    BMJ Oncol

  16. GO AE, Feliciano EJG, Martinez J, Ho FDV, et al
    Global determinants of cervical cancer outcomes: a health systems analysis.
    BMJ Oncol. 2026;5:e000975.
    PubMed         Abstract available


    CA Cancer J Clin


  17. Correction to "Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline".
    CA Cancer J Clin. 2026;76:e70066.
    PubMed        


    Cancer Control

  18. KULJARUSNONT S, Karnchanabanyong W, Ruengkhachorn I, Ularnwong M, et al
    Comparative Performance of Visual Inspection with Acetic Acid and Colposcopy for Detection of Cervical Precancer in Women with High-Risk Human Papillomavirus Infection: A Cross-Sectional Study.
    Cancer Control. 2026;33:10732748261422014.
    PubMed         Abstract available


    Cancer Gene Ther

  19. WAN Y, He Y, Chen X, Wang S, et al
    Effective delivery of genome editor to cervical cancer targeting Mcl1 for cancer therapy.
    Cancer Gene Ther. 2026 Jan 27. doi: 10.1038/s41417-025-00958.
    PubMed         Abstract available


    Cancer Genet

  20. POLEBOYINA PK, Pawar SC
    Elucidation of MMP-9 expression and association of MMP-9 rs3918242-1562 C/T promoter polymorphism in the progression of cervical cancer.
    Cancer Genet. 2026;302-303:79-92.
    PubMed         Abstract available


    Cancer Lett

  21. YUAN M, Hong Y, Feng Y, Sun J, et al
    Cervical Cancer Incidence and Mortality Trends in China: The role of Screening.
    Cancer Lett. 2026 Jan 27:218286. doi: 10.1016/j.canlet.2026.218286.
    PubMed         Abstract available


    Cancer Med

  22. BONLOKKE S, Blaakaer J, Steiniche T, Iachina M, et al
    Increased Risk of Second Squamous Cell Carcinomas Following Cervical Cancer: A Nationwide Danish Case-Control Study.
    Cancer Med. 2026;15:e71559.
    PubMed         Abstract available

  23. CHEN L, Liu L, Lin F, Fu Y, et al
    Development and Validation of Prediction Models for the Prognosis of Clear Cell Adenocarcinoma of the Cervix: A Population-Based Cohort Study.
    Cancer Med. 2026;15:e71585.
    PubMed         Abstract available


    Cancers (Basel)

  24. KARNIK M, Tulimilli SV, Anantharaju PG, Bettadapura ADS, et al
    An Overview of the Mechanisms of HPV-Induced Cervical Cancer: The Role of Kinase Targets in Pathogenesis and Drug Resistance.
    Cancers (Basel). 2026;18:318.
    PubMed         Abstract available

  25. DU M, Zheng Z, Lu P, Wang W, et al
    Oncological Outcomes and Genomic Features of Gastric-Type Endocervical Adenocarcinoma, the Most Aggressive and Common HPV-Independent Cervical Cancer.
    Cancers (Basel). 2026;18:320.
    PubMed         Abstract available

  26. KIM J, Jang J, Tewari KS, Kim KS, et al
    Nationwide Survival Impact of Bevacizumab Under National Reimbursement for Advanced Cervical Cancer in South Korea.
    Cancers (Basel). 2026;18:346.
    PubMed         Abstract available


    Cells

  27. SEMENOV DV, Tatarnikova IS, Chesnokova AS, Talyshev VA, et al
    Single-Cell Transcriptomic Landscape of Cervical Cancer Cell Lines Before and After Chemoradiotherapy.
    Cells. 2026;15:115.
    PubMed         Abstract available


    Curr Med Chem

  28. XIAO Y, Zhao Y, Wang Z, Peng C, et al
    Ferroptosis Targeting by beta-Sitosterol in Cervical Cancer Radiotherapy.
    Curr Med Chem. 2026 Jan 19. doi: 10.2174/0109298673409273251103055503.
    PubMed         Abstract available


    Curr Oncol

  29. XIAO H, Guo F, Wang Z, Pei K, et al
    Is Moderately Hypofractionated Radiotherapy a Safe and Effective Strategy for Cervical Cancer?-A Review of Current Evidence.
    Curr Oncol. 2026;33:24.
    PubMed         Abstract available

  30. NAGDEV P, Chittilla M
    Advances in Screening, Immunotherapy, Targeted Agents, and Precision Surgery in Cervical Cancer: A Comprehensive Clinical Review (2018-2025).
    Curr Oncol. 2026;33:48.
    PubMed         Abstract available

  31. WILKINSON AN, Wright K, Savage C, Pearl D, et al
    Towards Cervical Cancer Elimination: Insights from an In-Depth Regional Review of Patients with Cervical Cancer.
    Curr Oncol. 2026;33:52.
    PubMed         Abstract available


    Curr Pharm Biotechnol

  32. SHARMA S, Verma M, Rautela I, Khan F, et al
    Tumor Microenvironment: From Cervical Carcinogenesis to Therapeutic Advancements.
    Curr Pharm Biotechnol. 2025;26:2065-2081.
    PubMed         Abstract available


    Digit Health

  33. LIU Y, Wu R, Zhang L
    A cross-sectional study on the quality of cervical cancer health information across multiple short video platforms: Analysis of content, quality, and dissemination characteristics.
    Digit Health. 2026;12:20552076261415927.
    PubMed         Abstract available

  34. JIA X, Da X, Shi J, Wang Y, et al
    Digital health interventions for cervical cancer screening among hard-to-reach women in health-resource-limited areas: Protocol for a controlled trial with historical controls and two randomised intervention arms.
    Digit Health. 2026;12:20552076261416317.
    PubMed         Abstract available


    Ecancermedicalscience

  35. GOVENDER S, Phillips TK, Walter FM, Day S, et al
    Cervical cancer awareness among women recently diagnosed with cervical cancer in South Africa and Zimbabwe.
    Ecancermedicalscience. 2025;19:2018.
    PubMed         Abstract available


    Front Biosci (Landmark Ed)

  36. GU X, Yang Y, Zhang Z, Ouyang Y, et al
    Long Non-Coding RNA RAB11B-AS1 Suppresses Cervical Cancer Progression by Upregulating RPL26 Expression.
    Front Biosci (Landmark Ed). 2026;31:47597.
    PubMed         Abstract available


    Front Immunol

  37. WANG Z, Zhang H, Zhu Y, Jiang Y, et al
    Comprehensive evaluation of prophylactic HPV vaccines: a systematic review and meta-analysis of efficacy, safety, and immunogenicity in males and females.
    Front Immunol. 2026;16:1747082.
    PubMed         Abstract available

  38. ZHUANG Q, Liu Y
    Efficacy and safety of Cadonilimab in the treatment of recurrent/metastatic and advanced cervical cancer: a systematic review and meta-analysis.
    Front Immunol. 2026;16:1729380.
    PubMed         Abstract available

  39. YU H, Chen J, Lin J, Chen L, et al
    Cadonilimab rechallenge in patients with recurrent or metastatic cervical cancer following prior PD-1/PD-L1 inhibitor failure: a retrospective multicenter study.
    Front Immunol. 2026;16:1701319.
    PubMed         Abstract available


    Front Oncol

  40. WU Z, Huang C, Li R, Li H, et al
    Correction: PRKCI mediates radiosensitivity via the Hedgehog/GLI1 pathway in cervical cancer.
    Front Oncol. 2026;16:1765010.
    PubMed         Abstract available


    Hum Mutat

  41. JI R, Geng R, Zhang Z, Gao F, et al
    Exploring the Dynamic Changes of Intercellular Connections in Cervical Cancer: Insights From Transcriptomic Data Combined With Single-Cell Sequencing.
    Hum Mutat. 2026;2026:8140041.
    PubMed         Abstract available


    In Silico Pharmacol

  42. PANDIT SK, Sen B, Kumar P, Tripathi A, et al
    Anti-cervical cancer potential of apigenin, daidzein, and isokaempferide of Glycyrrhiza glabra Linn. Methanolic extract via network pharmacological analysis.
    In Silico Pharmacol. 2026;14:44.
    PubMed         Abstract available


    Infect Agent Cancer

  43. KHORRAMABADI SM, Ebrahimi N, Aghbash PS, Ravanlo ZZ, et al
    Silencing HPV: the rise of RNA therapeutics in cervical cancer.
    Infect Agent Cancer. 2026 Jan 29. doi: 10.1186/s13027-026-00733.
    PubMed         Abstract available


    Int Cancer Conf J

  44. OMI M, Saito M, Nishino S, Fusegi A, et al
    Case report on critical well-leg compartment syndrome: early diagnosis and treatment after cervical cancer surgery.
    Int Cancer Conf J. 2025;15:25-29.
    PubMed         Abstract available


    Int J Cancer

  45. REDL E, Herzog C, Vavourakis C, Barrett J, et al
    The cervico-vaginal DNA methylation WID-qEC test: An epigenetic marker associated with ovarian cancer in the absence of endometrial and cervical cancer.
    Int J Cancer. 2026 Jan 29. doi: 10.1002/ijc.70354.
    PubMed         Abstract available

  46. KROON KR, Bogaards JA, Berkhof J
    Cost-effectiveness analysis of human papillomavirus (HPV) genotyping strategies for management of HPV-positive women in cervical cancer screening.
    Int J Cancer. 2026 Jan 28. doi: 10.1002/ijc.70344.
    PubMed         Abstract available

  47. GIES S, Pohlers M, Tanzer T, Ampofo E, et al
    Th17 cells favor migration and invasiveness of cervical cancer cells under hypoxia in an IGF2BP2-dependent manner.
    Int J Cancer. 2026 Jan 24. doi: 10.1002/ijc.70340.
    PubMed         Abstract available

  48. NOMM O, Innos K, Jasilionis D, Krumins J, et al
    Educational inequalities in cervical cancer mortality in the Baltic countries and Finland in the context of organized screening: A register-based study 2000-2015.
    Int J Cancer. 2026 Jan 24. doi: 10.1002/ijc.70339.
    PubMed         Abstract available


    Int J Clin Oncol

  49. UMEMIYA M, Kou K, Inayama Y, Kamei J, et al
    Comparison of nedaplatin and cisplatin in concurrent chemoradiotherapy for cervical cancer: a systematic review and meta-analysis.
    Int J Clin Oncol. 2026 Jan 29. doi: 10.1007/s10147-026-02968.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  50. HOFFMANN S, Trif L, Kramer B, Neis F, et al
    PelviSound L-Real-time intraoperative sonographic assessment of pelvic sentinel lymph nodes using a drop-in probe in endometrial and cervical cancer during minimally invasive surgery: A single-center pilot feasibility study in 20 patients.
    Int J Gynaecol Obstet. 2026 Jan 29. doi: 10.1002/ijgo.70838.
    PubMed         Abstract available


    Int J Gynecol Cancer

  51. HU Y, Cheng H, Chen J, Chen S, et al
    Neoadjuvant chemotherapy plus cadonilimab followed by extra-fascial hysterectomy for International Federation of Gynecology and Obstetrics stage IB2 cervical cancer: a prospective, multi-center, single-arm, phase 2 trial.
    Int J Gynecol Cancer. 2026 Jan 5:104457. doi: 10.1016/j.ijgc.2025.104457.
    PubMed         Abstract available


    Int J Med Sci

  52. SUN Y, Zhang J, Guo L, Zhang J, et al
    Discovering the abnormalities and functional importance of ferroptosis-related molecules in cervical cancer.
    Int J Med Sci. 2026;23:443-460.
    PubMed         Abstract available


    Int J Mol Sci

  53. LAGUNAS-CRUZ MDC, Valle-Mendiola A, Soto-Cruz I
    The Vaginal Microbiome and Host Health: Implications for Cervical Cancer Progression.
    Int J Mol Sci. 2026;27:640.
    PubMed         Abstract available

  54. MARTINEZ-RAMIREZ I, Munoz-Bello JO, Contreras-Paredes A, Parra-Hernandez E, et al
    Cholesterol Metabolism: An Ally in the Development and Progression of Cervical Cancer.
    Int J Mol Sci. 2026;27:591.
    PubMed         Abstract available

  55. LEGAKI E, Lappa T, Prasoula KL, Kardasi Z, et al
    HPV-Driven Cervical Carcinogenesis: Genetic and Epigenetic Mechanisms and Diagnostic Approaches.
    Int J Mol Sci. 2026;27:803.
    PubMed         Abstract available


    Ir Med J

  56. SELVAJOTHI J, Hewitt M, de Haan A, Ting S, et al
    Managing women with cervical cancer symptoms: Cervical One-Stop Assessment Clinic.
    Ir Med J. 2026;119:9.
    PubMed         Abstract available


    J Cell Mol Med

  57. HUANG C, Pang G, Lang X, Zhang J, et al
    Single-Cell RNA Sequencing Analysis Reveals Correlation Between Immune Cell Composition and Gene Expression in Cervical Cancer.
    J Cell Mol Med. 2026;30:e70998.
    PubMed         Abstract available


    J Gynecol Oncol

  58. PITAKKARNKUL S, Tangjitgamol S, Sangariyavanich E, Buasom R, et al
    The situation of gynecological cancers in Thailand: incidence, histopathology, and survival outcomes from national cancer registry data.
    J Gynecol Oncol. 2026;37:e56.
    PubMed         Abstract available


    J Health Popul Nutr

  59. ZHENG H, Gao M, Xu H, Cai J, et al
    Initial different human papillomavirus infection statuses and subsequent infection risk: a decade-long longitudinal study.
    J Health Popul Nutr. 2025;45:32.
    PubMed         Abstract available


    J Low Genit Tract Dis

  60. LEONI F, Giorgi Rossi P, Morana C, Marchione R, et al
    Conservative Management of CIN2 Within Primary HPV Cervical Cancer Screening Programme: A Cohort Study.
    J Low Genit Tract Dis. 2026 Jan 26. doi: 10.1097/LGT.0000000000000930.
    PubMed         Abstract available


    J Surg Oncol

  61. NGUYEN AT, Duckworth ED, Li RA, Adam TH, et al
    Cervical Cancer Prevention and Treatment Disparities Among Native Hawaiian and Pacific Islanders: A Systematic Review and Meta-Analysis.
    J Surg Oncol. 2026 Jan 28. doi: 10.1002/jso.70200.
    PubMed         Abstract available


    JNCI Cancer Spectr

  62. AMBOREE TL, Dorali P, Damgacioglu H, Montealegre JR, et al
    The cervical cancer divide: State variation in incidence, mortality, and progress toward elimination in the US.
    JNCI Cancer Spectr. 2026 Jan 25:pkag005. doi: 10.1093.
    PubMed         Abstract available


    Lancet Public Health

  63. SULTANA F, Smith M, Saville M, Bateson D, et al
    Uptake and performance of self-collection offered through primary care to all eligible participants in a national cervical screening programme in Australia: a retrospective cohort study.
    Lancet Public Health. 2026;11:e101-e110.
    PubMed         Abstract available

  64. ELFSTROM KM, Dillner J
    Towards faster, better, and cheaper cervical cancer screening.
    Lancet Public Health. 2026;11:e72-e73.
    PubMed        


    Life (Basel)

  65. PATINO-MORALES CC, Jaime-Cruz R, Gonzalez-Perez R, Villavicencio-Guzman L, et al
    The Chick Embryo Chorioallantoic Membrane Assay as a Short-Term Exploratory Model for Cervical Cancer Research.
    Life (Basel). 2026;16:135.
    PubMed         Abstract available


    Medicina (Kaunas)

  66. IBIS K, Aydin MH, Kokce K, Suncak L, et al
    The "Undefined and Ignored Normal Tissue" Bulboclitoral Complex in Locally Advanced Cervical Cancer Treated with Definitive Radiochemotherapy: Is It Not the Organ at Risk?
    Medicina (Kaunas). 2025;62:14.
    PubMed         Abstract available

  67. GORGULU G, Sanci M
    Perspectives from Hysterectomy Specimens on the Hidden Malignancy Risk in HSIL Patients with Surgical Margin Continuity.
    Medicina (Kaunas). 2025;62:77.
    PubMed         Abstract available

  68. TOROMANI G, Saglimbeni GS, Upadhyayula BS, Manu E, et al
    Comprehensive Genomic Characterization of 102 Cervical Adenocarcinoma Tumors.
    Medicina (Kaunas). 2026;62:123.
    PubMed         Abstract available


    Medicine (Baltimore)

  69. LI J, Zhong X, Mou Y, Tao X, et al
    Identification of dephosphorylation related genes prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Medicine (Baltimore). 2026;105:e47292.
    PubMed         Abstract available


    Mol Oncol

  70. SAMBATH J, George IA, Manda SS, Ariyannur P, et al
    Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer.
    Mol Oncol. 2026 Jan 26. doi: 10.1002/1878-0261.70108.
    PubMed         Abstract available


    Molecules

  71. HUSSAIN SS, Maisam M, Younas S, Wang F, et al
    From Functional Food to Therapeutic Prospect: Mechanistic Study of Gypenoside XVII in HeLa Cells.
    Molecules. 2026;31:214.
    PubMed         Abstract available


    Nat Commun

  72. MABIKA-OBANDA AKF, Ambounda Ledaga N, Ngou Milama K, Zang Obame V, et al
    Vaccine-preventable HPV burden and cervical abnormalities in women during 2022-2024 Octobre Rose campaigns in Libreville.
    Nat Commun. 2025;17:1032.
    PubMed         Abstract available


    Nutrients

  73. CINTONI M, Autorino R, Rinaldi RM, Leonardi E, et al
    Clinical Tolerability and Safety of Ketogenic Diet in Patients with Gynecological Malignancies Undergoing Radiotherapy: Preliminary Results of a Prospective, Randomized, Open-Label Trial (KOMPARC).
    Nutrients. 2026;18:312.
    PubMed         Abstract available


    Oncol Lett

  74. DE LA CRUZ-HERNANDEZ E, Morales-Sandoval GC, Lizano M, Aviles-Salas A, et al
    Prognostic value of glioma-associated oncogene homolog 1 and SET domain-containing protein 2 immunohistochemical scores in locally advanced cervical cancer.
    Oncol Lett. 2026;31:105.
    PubMed         Abstract available


    Oncol Res


  75. Retraction: miR-126-5p Restoration Promotes Cell Apoptosis in Cervical Cancer by Targeting Bcl2l2.
    Oncol Res. 2026;34:30.
    PubMed         Abstract available


    Pharmaceuticals (Basel)

  76. DAVID LL, Singh M
    Functionalized Core/Shell Gold-Palladium Bimetallic Nanoparticles in Transferrin-Targeted Dual-Drug Delivery in a Cervical Cancer Cell Model.
    Pharmaceuticals (Basel). 2025;19:74.
    PubMed         Abstract available


    Public Health Res Pract

  77. VENGHATERI JB, Nathani P, Kaur J, Gadgil A, et al
    India's Path to Cervical Cancer Control: From Obstacles to Opportunities in HPV Vaccine Uptake.
    Public Health Res Pract. 2026 Jan 20:PU25036. doi: 10.1071/PU25036.
    PubMed         Abstract available


    Reprod Health

  78. HAHN E, Zakaras JM, Balasubramanian A, Russo A, et al
    Identifying gaps in women's preventive health services for women living with HIV in Vermont.
    Reprod Health. 2025;23:15.
    PubMed         Abstract available


    Sci Rep

  79. ZENG L, Chen Z, Wang K, Yi C, et al
    Epidemiology and prevention of HPV-driven cervical cancer in urban-rural China: a population-based study of 60,280 women.
    Sci Rep. 2026;16:3937.
    PubMed         Abstract available

  80. ASEFA T, Endale HT, Mengstie TA, Getnet M, et al
    Determinants of cervical cancer screening among women living with HIV in Lesotho using nationally representative 2023/24 DHS data.
    Sci Rep. 2026 Jan 28. doi: 10.1038/s41598-026-37180.
    PubMed         Abstract available


    Virol J

  81. EMADI SH, Ahmad S, Rahmanian M, Baharlou R, et al
    Design and computational evaluation of a prophylactic and therapeutic multi-epitope vaccine candidate against cervical cancer.
    Virol J. 2026 Jan 27. doi: 10.1186/s12985-026-03072.
    PubMed         Abstract available


    Viruses

  82. KONDLO S, Giyose N, Businge CB, Mbulawa ZZA, et al
    Human Papillomavirus Genotype Landscape Across Cervical Cytology Grades and Impact of HIV Among Women of Eastern Cape Province, South Africa.
    Viruses. 2025;18:65.
    PubMed         Abstract available


    Zhonghua Fu Chan Ke Za Zhi

  83. XIAO FY, Ma RC, Wang YX, Zhou JW, et al
    [Value of self-sampling cervical exfoliated cells of HPV E6/E7 mRNA detection in cervical cancer screening: a multicenter clinical study].
    Zhonghua Fu Chan Ke Za Zhi. 2026;61:60-66.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum